News

After seeking a second opinion at Saint Luke's, Mark Levin now walks tall—and pain free—knowing the right medical team, and a little faith, can work wonders.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

The new ultrasound probe, which will primarily be used in the hospital's emergency department, provides a detailed view of what's happening in a patient's body in real-time.

Cardiovascular Business spoke with Dr. Timothy Bateman about his views on SPECT advances and its longevity in the coming years.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Dr. Timothy Bateman spoke with Cardiovascular Business about his group's findings and what it is like to work with flurpiridaz.

When John Murray was losing function in his hands and arms, it became difficult to play his music. He turned to the team at Saint Luke's Marion Bloch Neuroscience Institute to fix the issue threatening his independent lifestyle.

Over the years, they have done everything together: graduated high school, tied the knot, bought their first home, and raised a family. For all they have shared, they never dreamed of sharing a cancer diagnosis.